Quercetin

Quercetin

SCHEMBL444562

O=C(C=Cc1ccccc1)c1ccccc1.O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.67
KMT2A Q03164 9/20 0.67
CYP1A2 P05177 7/20 0.67
CYP3A4 P08684 6/20 0.67
KDM4E B2RXH2 6/20 0.67
HSD17B10 Q99714 6/20 0.67
CYP1A1 P04798 6/20 0.67
CYP1B1 Q16678 6/20 0.67
MAPT P10636 6/20 0.67
CYP2C9 P11712 5/20 0.67
RECQL P46063 5/20 0.67
XDH P47989 5/20 0.67
ABCB1 P08183 5/20 0.67
IPMK Q8NFU5 5/20 0.67
IP6K2 Q9UHH9 5/20 0.67
APP P05067 5/20 0.67
ALOX15 P16050 4/20 0.67
HIF1A Q16665 4/20 0.67
POLB P06746 4/20 0.67
BCHE P06276 4/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quercetin SCHEMBL25221565 1.00 MEN1 (0.67) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL1419754 0.89 MEN1 (0.62) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL31408199 0.85 MEN1 (0.79) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL29037564 0.85 MEN1 (0.79) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL10860052 0.85 MEN1 (0.79) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL25190629 0.84 KMT2A (0.61) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL5083988 0.83 MEN1 (0.65) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL3958393 0.83 MEN1 (0.87) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL4173190 0.83 MEN1 (0.87) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL28196529 0.83 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130251697-A1 NOVEL NASAL SPRAY ALBRITTON IV FORD D (US) 2013-09-26 US claimed
EP-1545579-A1 COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND PHYTOCHEMICAL COMPOUNDS, AND METHODS RELATED THERETO PROCYTE CORPORATION (US) 2005-06-29 EP claimed
US-20040180102-A1 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto PROCYTE CORPORATION 2004-09-16 US claimed
WO-2004014413-A1 COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND PHYTOCHEMICAL COMPOUNDS, AND METHODS RELATED THERETO PROCYTE CORPORATION (US) 2004-02-19 WO claimed
WO-2003026705-A1 METHODS FOR STERILIZING BIOLOGICAL MATERIALS USING FLAVONOID/FLAVONOL STABILIZERS CLEARANT, INC. (US) 2003-04-03 WO claimed
US-20030059338-A1 Methods for sterilizing biological materials using flavonoid/flavonol stabilizers CLEARANT, INC. 2003-03-27 US claimed
US-5977184-A ANTIALLERGENS THORNE RESEARCH, INC. (US) 1999-11-02 US claimed
US-20240238184-A1 ANTI-INFLAMMATORY PEPTIDES, AND USES THEREOF NURITAS LIMITED (IE) 2024-07-18 US disclosed
US-20230355704-A1 GROWTH PROMOTING PEPTIDES, AND USES THEREOF NURITAS LIMITED (IE) 2023-11-09 US disclosed
US-11779531-B2 Anti-inflammatory peptides, and uses thereof NURITAS LIMITED (IE) 2023-10-10 US disclosed
US-11753389-B2 Method for preparing dihydroquercetin HEFEI LIFEON PHARMACEUTICAL CO., LTD. (CN) 2023-09-12 US disclosed
EP-4219521-A2 CELLULAR GROWTH PROMOTING PEPTIDES DERIVED FROM RICE PROTEINS (ORYZA SATIVA) AND USES THEREOF Nuritas Limited (IE) 2023-08-02 EP disclosed
US-11707500-B2 Growth promoting peptides, and uses thereof NURITAS LIMITED (IE) 2023-07-25 US disclosed
WO-2003026704-A1 METHODS OF STERILIZING BIOLOGICAL MIXTURES USING STABILIZER MIXTURES CLEARANT, INC. (US) 2003-04-03 WO disclosed
US-20030059338-A1 Methods for sterilizing biological materials using flavonoid/flavonol stabilizers CLEARANT, INC. 2003-03-27 US disclosed
WO-2003011873-A2 NATURAL MARINE SOURCE PHOSPHOLIPIDS COMPRISING FLAVONOIDS, POLYUNSATURATED FATTY ACIDS AND THEIR APPLICATIONS NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. (CA) 2003-02-13 WO disclosed
US-20030012687-A1 Methods of sterilizing biological materials CLEARANT, INC. 2003-01-16 US disclosed
US-5977184-A ANTIALLERGENS THORNE RESEARCH, INC. (US) 1999-11-02 US disclosed
US-5977184-A ANTIALLERGENS THORNE RESEARCH, INC. (US) 1999-11-02 US disclosed
US-5977184-A ANTIALLERGENS THORNE RESEARCH, INC. (US) 1999-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180102-A1 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto HMOX1, HES1, SOD1 MEN1 2919/4885KMT2A 4455/4885CYP1A2 3010/4885
US-11753389-B2 Method for preparing dihydroquercetin QDPR, DPYD, DHODH MEN1 3269/4885KMT2A 3711/4885CYP1A2 932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.